Patents by Inventor Kellisa Beth HANSEN

Kellisa Beth HANSEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereof
    Patent number: 11904053
    Abstract: The present technology relates generally to dry powder formulations of antibodies specific for thymic stromal lymphopoietin (TSLP), as well as methods of treating asthma, using the dry powder formulations, suitably via pulmonary delivery.
    Type: Grant
    Filed: October 27, 2020
    Date of Patent: February 20, 2024
    Assignee: MEDIMMUNE LIMITED
    Inventors: Catherine Eugenie Chaillan Huntington, Susan Hoe, Prakash Manikwar, Roland Wilhelm Kolbeck, Emma Suzanne Cohen, David Lechuga-Ballesteros, Kellisa Beth Hansen, Dexter Joseph D'Sa, Saba Ghazvini
  • Dry Powder Formulations of Thymic Stromal Lymphopoietin (TSLP)-Binding Antibodies and Methods of Use Thereof
    Publication number: 20230201120
    Abstract: The present technology relates generally to dry powder formulations of antibodies specific for thymic stromal lymphopoietin (TSLP), as well as methods of treating asthma, using the dry powder formulations, suitably via pulmonary delivery.
    Type: Application
    Filed: November 9, 2022
    Publication date: June 29, 2023
    Inventors: Catherine Eugenie Chaillan Huntington, Susan Hoe, Prakash Manikwar, Roland Wilhelm Kolbeck, Emma Suzanne Cohen, David Lechuga-Ballesteros, Kellisa Beth Hansen, Dexter Joseph D'sa, Saba Ghazvini
  • DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINE
    Publication number: 20220401365
    Abstract: The present technology relates generally to dry powder formulations comprising leucine and trileucine in specific ratios that are suitable for pulmonary delivery. Also provided are methods of preparing the dry powder formulations, and methods of administration and treatment using the dry powder formulations.
    Type: Application
    Filed: October 27, 2020
    Publication date: December 22, 2022
    Inventors: Prakash MANIKWAR, David LECHUGA-BALLESTEROS, Susan HOE, Kellisa Beth HANSEN, Dexter Joseph D'SA, Saba GHAZVINI